Jennifer Tremmel
Academic Appointments
- Instructor, Medicine - Cardiovascular Medicine
Contact Information
-
Clinical Offices
Interventional Cardiology 300 Pasteur Dr H2103 MC 5218 Stanford, CA 94305 Tel Work (650) 723-0180 Fax (650) 725-6766
- Academic Offices
Personal Information Tel (650) 723-0180 Tel (650) 724-9096Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cardiology (Heart)
- Cardiovascular Disease
- Women's Heart Health
- Women's Cardiovascular Disease
Administrative Appointments
- Clinical Director, Women's Heart Health at Stanford (2007 - present)
- Director, Secondary Prevention Program (2006 - present)
Professional Education
| Board Certification: | Interventional Cardiology, American Board of Internal Medicine (2007) |
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (2006) |
| Fellowship: | SUMC - Graduate Medical Education, CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2001) |
| Residency: | Dartmouth Hitchcock Medical Center, NH (2001) |
Web Site Links
Scientific Focus
Current Research Interests
Dr. Tremmel studies sex differences in cardiovascular disease. She is currently investigating sex differences in coronary endothelial function, plaque deposition, and the microcirculation of women and men who present with chest pain, but have normal appearing coronary arteries by angiography. She is also leading Stanford’s participation in the multi-center VIRGO trial, which is evaluating sex differences in young patients who present with myocardial infarction. Other active research projects include sex differences in chronic total coronary occlusions, the impact of stress on anginal symptoms, and vascular access site complications. Dr. Tremmel keeps Stanford’s Tako-tsubo Patient Registry and is conducting a multi-center study to investigate the relationship of stress and coping to genetic polymorphisms in patients with Tako-tsubo.
Clinical Trials
Publications
- Launching a successful transradial program. J Invasive Cardiol. 2009; (8 Suppl A): 3A-10A
- Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008; (5): 560-5
- Ischemic heart disease in women: an appropriate time to discriminate. Rev Cardiovasc Med. 2007; (2): 61-8
- Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy. J Interv Cardiol. 2006; (1): 75-9
- The influence of body mass index on mortality following percutaneous coronary intervention in those presenting with unstable angina or non-ST elevation myocardial infarction: is there an obesity paradox? Am J Cardiol. 2005; (7,supp1): 106H
Help